Barclays raised the firm’s price target on CME Group to $247 from $230 and keeps an Overweight rating on the shares. The analyst updated brokers, asset managers and exchange models for Q3 given the intra-quarter metrics. Volatility was quite low for most of the quarter, while share shifts and idiosyncratic events drove other changes, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CME:
- CME Group achieves record volume in Aluminum futures contract in Q3
- CME Group reached ADV of 22.7M contracts in September
- CME Group price target raised to $210 from $204 at BofA
- CME Group to launch Micro Henry Hub futures and options on November 6
- CME Group to launch Cobalt Hydroxide futures on October 23